Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents.Liu, S., Neidhardt, E.A., Grossman, T.H., Ocain, T., Clardy, J.
(2000) Structure 8: 25-33
- PubMed: 10673429
- DOI: https://doi.org/10.1016/s0969-2126(00)00077-0
- Primary Citation of Related Structures:
- PubMed Abstract:
Dihydroorotate dehydrogenase (DHODH) catalyzes the fourth committed step in the de novo biosynthesis of pyrimidines. As rapidly proliferating human T cells have an exceptional requirement for de novo pyrimidine biosynthesis, small molecule DHODH inhibitors constitute an attractive therapeutic approach to autoimmune diseases, immunosuppression, and cancer. Neither the structure of human DHODH nor any member of its family was known.
Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853-1301, USA.